IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tanaka Capital Management Inc

Q3 2020 Holdings

Filed 2020-11-13 | 53 holdings | $2.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Catalyst Pharmaceuticals(CPRX)COM14888U101$749.0K252,19938.3%
PreviousPage 2 of 2